NCT03200132View on ClinicalTrials.gov

Respiratory Motion Correction of Cardiac Combined Positron Emission Tomography and Magnetic Resonance Imaging (PET/MRI)

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

June 26, 2017

Primary Completion Date

October 14, 2021

Study Completion Date

October 14, 2021

Conditions
Cardiac Imaging
Interventions
DIAGNOSTIC_TEST

Cardiac PET/MRI

For patients undergoing 18-Fluor- fluorodeoxyglucose (18F-FDG) PET/MRI or PET/Computed Tomography (CT), additional cardiac PET/MRI scans are acquired.

Trial Locations (1)

6229HX

Maastricht University Hospital, Maastricht

All Listed Sponsors
lead

Maastricht University Medical Center

OTHER

NCT03200132 - Respiratory Motion Correction of Cardiac Combined Positron Emission Tomography and Magnetic Resonance Imaging (PET/MRI) | Biotech Hunter | Biotech Hunter